Pacer Advisors Inc. Sells 13,192 Shares of Ventas, Inc. $VTR

Pacer Advisors Inc. cut its holdings in shares of Ventas, Inc. (NYSE:VTR) by 27.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 34,580 shares of the real estate investment trust’s stock after selling 13,192 shares during the quarter. Pacer Advisors Inc.’s holdings in Ventas were worth $2,828,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. DV Trading LLC raised its position in shares of Ventas by 59,900.0% in the first quarter. DV Trading LLC now owns 3,000 shares of the real estate investment trust’s stock valued at $245,000 after purchasing an additional 2,995 shares during the period. Parallel Advisors LLC raised its stake in Ventas by 12.3% in the first quarter. Parallel Advisors LLC now owns 5,069 shares of the real estate investment trust’s stock valued at $415,000 after purchasing an additional 555 shares in the last quarter. Glenmede Trust Co. NA lifted its holdings in shares of Ventas by 3.7% during the 1st quarter. Glenmede Trust Co. NA now owns 10,124 shares of the real estate investment trust’s stock worth $828,000 after acquiring an additional 358 shares during the last quarter. Summitry LLC raised its position in Ventas by 14.6% during the first quarter. Summitry LLC now owns 4,907 shares of the real estate investment trust’s stock valued at $401,000 after purchasing an additional 627 shares in the last quarter. Finally, Groupe la Francaise bought a new stake in Ventas during the first quarter worth about $566,000. Institutional investors own 94.18% of the company’s stock.

Insider Transactions at Ventas

In other news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.53% of the stock is currently owned by insiders.

Ventas Stock Down 0.3%

Shares of NYSE VTR opened at $92.22 on Friday. The firm’s fifty day moving average is $89.32 and its 200 day moving average is $86.05. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The company has a market cap of $47.30 billion, a price-to-earnings ratio of 170.78, a PEG ratio of 2.14 and a beta of 0.69.

Ventas Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a $0.52 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Ventas’s payout ratio is presently 385.19%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on VTR shares. Cantor Fitzgerald upped their price objective on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Raymond James Financial initiated coverage on Ventas in a research report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 target price for the company. BMO Capital Markets reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research note on Monday, May 4th. Scotiabank reduced their price target on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Finally, KeyCorp lifted their price target on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and an average price target of $97.56.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.